For: | Greene CM, McElvaney NG. Z α-1 antitrypsin deficiency and the endoplasmic reticulum stress response. World J Gastrointest Pharmacol Ther 2010; 1(5): 94-101 [PMID: 21577302 DOI: 10.4292/wjgpt.v1.i5.94] |
---|---|
URL: | https://www.wjgnet.com/2150-5349/full/v1/i5/94.htm |
Number | Citing Articles |
1 |
Lata Kaphalia, William J. Calhoun. Alcoholic lung injury: Metabolic, biochemical and immunological aspects. Toxicology Letters 2013; 222(2): 171 doi: 10.1016/j.toxlet.2013.07.016
|
2 |
Prakash Baligar, Veena Kochat, Shailendra K. Arindkar, Zaffar Equbal, Snehashish Mukherjee, Swati Patel, Perumal Nagarajan, Sujata Mohanty, Jeffrey H. Teckman, Asok Mukhopadhyay. Bone marrow stem cell therapy partially ameliorates pathological consequences in livers of mice expressing mutant human α1‐antitrypsin. Hepatology 2017; 65(4): 1319 doi: 10.1002/hep.29027
|
3 |
Daria Sicari, Aeid Igbaria, Eric Chevet. Control of Protein Homeostasis in the Early Secretory Pathway: Current Status and Challenges. Cells 2019; 8(11): 1347 doi: 10.3390/cells8111347
|
4 |
Tom Luedde, Neil Kaplowitz, Robert F. Schwabe. Cell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical Relevance. Gastroenterology 2014; 147(4): 765 doi: 10.1053/j.gastro.2014.07.018
|
5 |
Margaret Brecker, Svetlana Khakhina, Tyler J. Schubert, Zachary Thompson, Ronald C. Rubenstein. The Probable, Possible, and Novel Functions of ERp29. Frontiers in Physiology 2020; 11 doi: 10.3389/fphys.2020.574339
|
6 |
Catherine M Greene, Tidi Hassan, Kevin Molloy, Noel G McElvaney. The role of proteases, endoplasmic reticulum stress andSERPINA1heterozygosity in lung disease and α-1 anti-trypsin deficiency. Expert Review of Respiratory Medicine 2011; 5(3): 395 doi: 10.1586/ers.11.20
|
7 |
Sebastian Fähndrich, Nikolas Bernhard, Philipp Lepper, Robert Bals. Alpha-1-Antitrypsin-Mangel: Pathophysiologie, Diagnostik und Therapie. Pneumo News 2018; 10(2): 31 doi: 10.1007/s15033-018-0813-2
|
8 |
Sang Won Park, Umut Ozcan. Potential for therapeutic manipulation of the UPR in disease. Seminars in Immunopathology 2013; 35(3): 351 doi: 10.1007/s00281-013-0370-z
|
9 |
Alejandro Costaguta, Fernando Alvarez. Cirrhosis: A practical guide to management. 2015; : 311 doi: 10.1002/9781118412640.ch28
|
10 |
Syamala Soumyakrishnan, Cheemachanahalli Muninanjappa Mohan Gowda, Shivanna Uma, Meghavarnam Anil Kumar, Sujatha Peela, Meenakshisundaram Sreepriya. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 219 doi: 10.1016/B978-0-323-98806-3.00009-X
|
11 |
Wanvisa Udomsinprasert. Interleukin-1 family cytokines in liver cell death: a new therapeutic target for liver diseases. Expert Opinion on Therapeutic Targets 2023; 27(11): 1125 doi: 10.1080/14728222.2023.2285763
|
12 |
Ilaria Ferrarotti, Marion Wencker, Joanna Chorostowska-Wynimko. Rare variants in alpha 1 antitrypsin deficiency: a systematic literature review. Orphanet Journal of Rare Diseases 2024; 19(1) doi: 10.1186/s13023-024-03069-1
|
13 |
Isabella Giovannoni, Francesco Callea, Marta Stefanelli, Riccardo Mariani, Filippo M. Santorelli, Paola Francalanci. Alpha‐1‐antitrypsin deficiency: from genoma to liver disease. PiZ mouse as model for the development of liver pathology in human. Liver International 2015; 35(1): 198 doi: 10.1111/liv.12504
|
14 |
Judith A Brebner, Robert A Stockley. Recent advances in α-1-antitrypsin deficiency-related lung disease. Expert Review of Respiratory Medicine 2013; 7(3): 213 doi: 10.1586/ers.13.20
|
15 |
James Wei, Sadaf Rahman, Ehab A. Ayaub, Jeffrey G. Dickhout, Kjetil Ask. Protein Misfolding and Endoplasmic Reticulum Stress in Chronic Lung Disease. Chest 2013; 143(4): 1098 doi: 10.1378/chest.12-2133
|
16 |
Yuanqing Lu, Liqun R. Wang, Jungnam Lee, Naweed S. Mohammad, Alek M. Aranyos, Calvin Gould, Nazli Khodayari, Regina A. Oshins, Craig G. Moneypenny, Mark L. Brantly. The unfolded protein response to PI*Z alpha‐1 antitrypsin in human hepatocellular and murine models. Hepatology Communications 2022; 6(9): 2354 doi: 10.1002/hep4.1997
|
17 |
Mahsa Ghasemzad, Mahdieh Hashemi, Zohre Miri Lavasani, Nikoo Hossein-khannazer, Haleh Bakhshandeh, Roberto Gramignoli, Hani Keshavarz Alikhani, Mustapha Najimi, Saman Nikeghbalian, Massoud Vosough. Novel Gene-Correction-Based Therapeutic Modalities for Monogenic Liver Disorders. Bioengineering 2022; 9(8): 392 doi: 10.3390/bioengineering9080392
|
18 |
Virginia C. Clark, Charlie Strange, Pavel Strnad, Antonio J. Sanchez, Paul Kwo, Vitor Magno Pereira, Bart van Hoek, Igor Barjaktarevic, Angelo Guido Corsico, Monica Pons, Monica Goldklang, Meagan Gray, Brooks Kuhn, Hugo E. Vargas, John M. Vierling, Raj Vuppalanchi, Mark Brantly, Naomi Kappe, Ting Chang, Thomas Schluep, Rong Zhou, James Hamilton, Javier San Martin, Rohit Loomba. Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA). Gastroenterology 2024; 167(5): 1008 doi: 10.1053/j.gastro.2024.06.028
|
19 |
Nazli Khodayari, Rejean L. Wang, Regina Oshins, Yuanqing Lu, Michael Millett, Alek M. Aranyos, Sayedamin Mostofizadeh, Yogesh Scindia, Tammy O. Flagg, Mark Brantly. The Mechanism of Mitochondrial Injury in Alpha-1 Antitrypsin Deficiency Mediated Liver Disease. International Journal of Molecular Sciences 2021; 22(24): 13255 doi: 10.3390/ijms222413255
|
20 |
Nazli Khodayari, Regina Oshins, Abdel A. Alli, Kubra M. Tuna, L. Shannon Holliday, Karina Krotova, Mark Brantly. Modulation of calreticulin expression reveals a novel exosome-mediated mechanism of Z variant α1-antitrypsin disposal. Journal of Biological Chemistry 2019; 294(16): 6240 doi: 10.1074/jbc.RA118.006142
|
21 |
Sabina Janciauskiene, Anders Wallmark, Eeva Piitulainen, Thomas Köhnlein, Tobias Welte, Tomas Sveger. Performance of enhanced liver fibrosis plasma markers in asymptomatic individuals with ZZ α1-antitrypsin deficiency. European Journal of Gastroenterology & Hepatology 2011; 23(8): 716 doi: 10.1097/MEG.0b013e328347daaf
|
22 |
P. Joly, L. Restier, M. Bouchecareilh, P. Lacan, F. Cabet, C. Chapuis-Cellier, A. Francina, A. Lachaux. Cohorte DEFI-ALPHA et projet hospitalier de recherche clinique POLYGEN DEFI-ALPHA. Étude des facteurs cliniques, biologiques et génétiques associés à l’apparition et à l’évolution de complications hépatiques chez les enfants présentant un déficit en alpha-1 antitrypsine. Revue des Maladies Respiratoires 2015; 32(7): 759 doi: 10.1016/j.rmr.2015.06.010
|
23 |
Christian Mueller, Qiushi Tang, Alisha Gruntman, Keith Blomenkamp, Jeffery Teckman, Lina Song, Phillip D Zamore, Terence R Flotte. Sustained miRNA-mediated Knockdown of Mutant AAT With Simultaneous Augmentation of Wild-type AAT Has Minimal Effect on Global Liver miRNA Profiles. Molecular Therapy 2012; 20(3): 590 doi: 10.1038/mt.2011.292
|
24 |
Nancy T. Malintan, Steven D. Buckingham, David A. Lomas, David B. Sattelle. Calcium signalling in mammalian cell lines expressing wild type and mutant human α1-Antitrypsin. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53535-1
|
25 |
Francisco J. Padilla-Godínez, Rodrigo Ramos-Acevedo, Hilda Angélica Martínez-Becerril, Luis D. Bernal-Conde, Jerónimo F. Garrido-Figueroa, Marcia Hiriart, Adriana Hernández-López, Rubén Argüero-Sánchez, Francesco Callea, Magdalena Guerra-Crespo. Protein Misfolding and Aggregation: The Relatedness between Parkinson’s Disease and Hepatic Endoplasmic Reticulum Storage Disorders. International Journal of Molecular Sciences 2021; 22(22): 12467 doi: 10.3390/ijms222212467
|
26 |
Laura Pini, Laura Tiberio, Narayanan Venkatesan, Michela Bezzi, Luciano Corda, Maurizio Luisetti, Ilaria Ferrarotti, Mario Malerba, David A Lomas, Sabina Janciauskiene, Enrico Vizzardi, Denise Modina, Luisa Schiaffonati, Claudio Tantucci. The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency. Respiratory Research 2014; 15(1) doi: 10.1186/s12931-014-0112-3
|
27 |
Tessa M. Cacciottolo, William T.H. Gelson, Gerald Maguire, Susan E. Davies, William J.H. Griffiths. Pi*Z heterozygous alpha-1 antitrypsin states accelerate parenchymal but not biliary cirrhosis. European Journal of Gastroenterology & Hepatology 2014; 26(4): 412 doi: 10.1097/MEG.0000000000000061
|
28 |
Margarita A. Sazonova, Vasily V. Sinyov, Anastasia I. Ryzhkova, Marina D. Sazonova, Tatiana V. Kirichenko, Victoria A. Khotina, Zukhra B. Khasanova, Natalya A. Doroschuk, Vasily P. Karagodin, Alexander N. Orekhov, Igor A. Sobenin. Some Molecular and Cellular Stress Mechanisms Associated with Neurodegenerative Diseases and Atherosclerosis. International Journal of Molecular Sciences 2021; 22(2): 699 doi: 10.3390/ijms22020699
|
29 |
Nanna J. Korsbæk, Eskild M. Landt, Sarah C. W. Marott, Børge G. Nordestgaard, Gabrielle R. Vinding, Gregor B. E. Jemec, Morten Dahl. Alpha‐1 antitrypsin deficiency associated with increased risks of skin cancer, leukemia, and hepatic cancer: A nationwide cohort study. Journal of Internal Medicine 2024; 296(6): 460 doi: 10.1111/joim.20016
|
30 |
Lata Kaphalia, Nahal Boroumand, Ju Hyunsu, Bhupendra S. Kaphalia, William J. Calhoun. Ethanol metabolism, oxidative stress, and endoplasmic reticulum stress responses in the lungs of hepatic alcohol dehydrogenase deficient deer mice after chronic ethanol feeding. Toxicology and Applied Pharmacology 2014; 277(2): 109 doi: 10.1016/j.taap.2014.02.018
|
31 |
Jungnam Lee, Naweed Mohammad, Yuanqing Lu, Keunsoo Kang, Kyudong Han, Mark Brantly. Alu RNA induces NLRP3 expression through TLR7 activation in α-1-antitrypsin–deficient macrophages. JCI Insight 2022; 7(12) doi: 10.1172/jci.insight.158791
|
32 |
Catherine Greene, Roohi Chhabra, Noel McElvaney. Is There a Therapeutic Role for Selenium in Alpha-1 Antitrypsin Deficiency?. Nutrients 2013; 5(3): 758 doi: 10.3390/nu5030758
|
33 |
Sung-Min Park, Tae-Il Kang, Jae-Seon So. Roles of XBP1s in Transcriptional Regulation of Target Genes. Biomedicines 2021; 9(7): 791 doi: 10.3390/biomedicines9070791
|